In the study by Ghorbani, which also included TTH patients, Mi was more prevalent in the normal group than in BC patients and, among these, was lower in ER+ PR− BC patients than ER− PR+ patients [12], thus suggesting that the protective role of Mi in BC development might be specific to ER + BC. This evidence concerns the gene MITF and breast cancer.